The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: A double-blind randomized controlled trial

Journal of Periodontal Research

Volumn 50, Issue 6, 2015, Pages 775-785

  Flichy Fernandez A J ^a   Ata Ali, J ^b   Alegre Domingo, T ^a   Candel Marti E ^a   Ata Ali, F ^b   Palacio, J R ^c   Penarrocha Diago M ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Dental implant; Lactobacillus reuteri; Peri implant mucositis; Probiotics

Indexed keywords

CYTOKINE; PLACEBO; PROBIOTIC AGENT; TABLET;

ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; AGED; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LACTOBACILLUS REUTERI; MALE; MIDDLE AGED; MUCOSITIS; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TABLET; TOOTH IMPLANTATION; TREATMENT OUTCOME;

AGED; CROSS-OVER STUDIES; CYTOKINES; DENTAL IMPLANTATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS REUTERI; MALE; MIDDLE AGED; MUCOSITIS; PLACEBOS; PROBIOTICS; PROSPECTIVE STUDIES; TABLETS; TREATMENT OUTCOME;

EID: 84945464180     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12264     Document Type: Article

References (48)

1. Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr Clin Care 2004;7:56-68.
2. Çaglar E, Kargul B, Tanboga I. Bacteriotherapy and probiotics' role on oral health. Oral Dis 2005;11:131-137.
3. Comelli EM, Guggenheim B, Stingele F, Neeser JR. Selection of dairy bacterial strains as probiotics for oral health. Eur J Oral Sci 2002;110:218-224.
4. Çaglar E, Cildir SK, Ergeneli S, Sandalli N, Twetman S. Salivary mutans streptococci and Lactobacilli levels after ingestion of the probiotic bacterium Lactobacilli reuteri ATCC 55739 by straws or tablets. Acta Odontol Scand 2006;64:314-318.
5. Grudianov AI, Dmitrieva NA, Fomenko EV. Use of probiotics Bifidumbacterin and Acilact in tablets in therapy of periodontal inflammations. Stomatologiia Mosk 2002;81:39-43.
6. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 2006;30:55-60.
7. Koll-Klais P, Mändar R, Leibur E, Marcotte H, Hammrström L, Mikelsaar M. Oral Lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 2005;20:354-361.
8. Twetman S, Derawi B, Keller M, Ekstrand K, Yucel-Lindberg T, Stecksen-Blicks C. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand 2009;67:19-24.
9. Harini PM, Anegundi RT. Efficacy of a probiotic and chlorhexidine mouth rinses: a short-term clinical study. J Indian Soc Pedod Prev Dent 2010;28:179-182.
10. Kang MS, Kim BG, Lee HC, Oh JS. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol 2006;33:226-232.
11. Hatakka K, Ahola AJ, Yli-Knuuttila H et al. Probiotics reduce the prevalence of oral candida in the elderly - a randomized controlled trial. J Dent Res 2007;86:125-130.
12. Flichy-Fernández AJ, Alegre-Domingo T, Peñarrocha-Oltra D, Peñarrocha-Diago M. Probiotic treatment in the oral cavity: an update. Med Oral Patol Cir Bucal 2010;15:677-680.
13. Zitzmann NU, Berglundh T. Definition of peri-implant diseases. J Clin Periodontol 2008;35:266-291.
14. Renvert S, Roos-Jansåker AM, Lindahl C, Renvert H, Rutger Persson G. Infection at titanium implants with or without a clinical diagnosis of inflammation. Clin Oral Implants Res 2007;18:509-516.
15. Ata-Ali J, Flichy-Fernández AJ, Alegre-Domingo T et al. Analysis of the peri-implant microbiota in 90 dental implants and its relationship to crevicular fluid volume. Med Oral Patol Oral Cir Bucal 2011;16:e944-e947.
16. Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002;13:349-358.
17. Ata-Ali J, Candel-Marti ME, Flichy-Fernández AJ, Peñarrocha-Oltra D, Balaguer-Martinez JF, Peñarrocha Diago M. Peri-implantitis: associated microbiota and treatment. Med Oral Patol Oral Cir Bucal 2011;16:e937-e943.
18. Jepsen S, Eberhard J, Fricke D, Hedderich J, Siebert R, Açil Y. Interleukin-1 gene polymorphisms and experimental gingivitis. J Clin Periodontol 2003;30:102-106.
19. Schierano G, Bassi F, Gassino G, Mareschi K, Bellone G, Preti G. Cytokine production and bone remodeling in patients wearing overdentures on oral implants. J Dent Res 2000;79:1675-1682.
20. Nowzari H, Botero JE, DeGiacomo M, Villacres MC, Rich SK. Microbiology and cytokine levels around healthy dental implants and teeth. Clin Implant Dent Relat Res 2008;10:166-173.
21. Güncü GN, Akman AC, Günday S, Yamalik N, Berker E. Effect of inflammation on cytokine levels and bone remodeling markers in peri-implant sulcus fluid: a preliminary report. Cytokine 2012;59:313-316.
22. Lin Y, Huang P, Lu X et al. The relationship between IL-1 gene polymorphism and marginal bone loss around dental implants. J Oral Maxillofac Surg 2007;65:2340-2344.
23. Shimpuku H, Nosaka Y, Kawamura T, Tachi Y, Shinohara M, Ohura K. Genetic polymorphisms of the interleukin-1 gene and early marginal bone loss around endosseous dental implants. Clin Oral Impl Res 2003;14:423-429.
24. Severino VO, Napimoga MH, Lima Pereira SA. Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis. Arch of Oral Biol 2011;56:823-828.
25. Petkovic AB, Matic SM, Stamatovic NV et al. Proinflammatory cytokines (IL-1β and TNF-α) and chemokines (IL-8 and MIP-1α) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg 2010;39:478-485.
26. Ata-Ali J, Flichy-Fernández AJ, Ata-Ali F, Peñarrocha-Diago MA, Peñarrocha-Diago M. Clinical, microbiologic, and host response characteristics in patients with peri-implant mucositis. Int J Oral Maxillofac Implants 2013;28:883-890.
27. Candel-Martí ME, Flichy-Fernández AJ, Alegre-Domingo T, Ata-Ali J, Peñarrocha-Diago MA. Interleukins IL-6, IL-8, IL-10, IL-12 and periimplant disease. An update. Med Oral Patol Oral Cir Bucal 2011;16:e518-e521.
28. Schwarz F, Sculean A, Rothamel D, Schwenzer K, Georg T, Becker J. Clinical evaluation of an Er: YAG laser for nonsurgical treatment of peri-implantitis: a pilot study. Clin Oral Implants Res 2005;16:44-52.
29. Lang NP, Berglundh T, Working group 4 of Seventh European Workshop on Periodontology. Periimplant diseases: where are we now?-Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 2011;38:178-181.
30. Duarte PM, de Mendonça AC, Máximo MB, Santos VR, Bastos MF, Nociti FH. Effect of anti-infective mechanical therapy on clinical parameters and cytokine levels in human peri-implant diseases. J Periodontol 2009;80:234-243.
31. Liskmann S, Vihalemm T, Salum O, Zilmer K, Fischer K, Zilmer M. Correlations between clinical parameters and interleukin-6 and interleukin-10 levels in saliva from totally edentulous patients with peri-implant disease. Int J Oral Maxillofac Implants 2006;21:543-550.
32. Mombelli A, Van Oosten MAC, Schürch E, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2:145-151.
33. Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res 1986;21:101-112.
34. Feil PH, Grauer JS, Gadbury-Amyot C, Kula K, McCunniff MD. Intentional use of the Hawthorne effect to improve oral hygiene compliance in orthodontic patients. J Dent Educ 2002;66:1129-1135.
35. Shimauchi H, Mayanagi G, Nakaya S et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J Clin Periodontol 2008;35:897-905.
36. Della Riccia DN, Bizzini F, Perilli MG et al. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis 2007;13:376-385.
37. Vicario M, Santos A, Violant D, Nart J, Giner L. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial. Acta Odontol Scand 2013;71:813-819.
38. Sinkiewicz G, Cronholm S, Ljunggren L, Dahlén G, Bratthall G. Influence of dietary supplementation with Lactobacillus reuteri on the oral flora of healthy subjects. Swed Dent J 2010;34:197-206.
39. Staab B, Eick S, Knöfler G, Jentsch H. The influence of a probiotic milk drink on the development of gingivitis: a pilot study. J Clin Periodontol 2009;36:850-856.
40. Iniesta M, Herrera D, Montero E et al. Probiotic effects of orally administered Lactobacillus reuteri containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. J Clin Periodontol 2012;39:736-744.
41. Renvert S, Roos-Jansåker AM, Claffey N. Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review. J Clin Periodontol 2008;35:305-315.
42. Porras R, Anderson GB, Caffesse R, Narendran S, Trejo PM. Clinical response to 2 different therapeutic regimens to treat peri-implant mucositis. J Periodontol 2002;73:1118-1125.
43. Felo A, Shibly O, Ciancio SG, Lauciello FR, Ho A. Effects of subgingival chlorexidine irrigation on peri-implant maintenance. Am J Dent 1997;10:107-110.
44. Ciancio SG, Lauciello F, Shibly O, Vitello M, Mather M. The effect of an antiseptic mouthrinse on implant maintenance: plaque and peri-implant gingival tissues. J Periodontol 1995;66:962-965.
45. Schenk G, Flemming TF, Betz T, Reuther J, Klaiber B. Controlled local delivery of periimplant mucosal hyperplasia and mucositis. A controlled case series. Clin Oral Implants Res 1997;8:427-433.
46. Strooker H, Rohn S, Van Winkelhoff AJ. Clinical and microbiological effects of chemical versus mechanical cleaning in professional supportive implant theraphy. Int J Oral Maxillofac Implants 1998;13:845-850.
47. Maekawa T, Hajishengallis G. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. J Periodontal Res 2014;49:785-791.
48. Dhingra K. Methodological issues in randomized trials assessing probiotics for periodontal treatment. J Periodontal Res 2012;47:15-26.